Dulaglutide
Brand name: Trulicity
Rank #4 of 500 drugs by total cost
$2.99B
Total Cost
2,175,100
Total Claims
$2.99B
Total Cost
49,007
Prescribers
$1,373
Cost per Claim
271,752
Beneficiaries
3,037,524
30-Day Fills
$61K
Avg Cost/Provider
44
Avg Claims/Provider
About Dulaglutide
Dulaglutide (sold as Trulicity) was prescribed 2,175,100 times by 49,007 Medicare Part D providers in 2023, costing the program $2.99B. At $1,373 per claim, this is a high-cost medication.
💰 This drug alone accounts for 1.1% of all Medicare Part D drug spending.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 1 | Apixaban (Eliquis) | $7.75B | 8,995,930 |
| 2 | Semaglutide (Ozempic) | $4.30B | 3,193,643 |
| 3 | Empagliflozin (Jardiance) | $3.58B | 3,334,784 |
| 4 | Dulaglutide (Trulicity) | $2.99B | 2,175,100 |
| 5 | Rivaroxaban (Xarelto) | $2.45B | 2,628,123 |
| 6 | Adalimumab (Humira(Cf) Pen) | $2.17B | 240,925 |
| 7 | Lenalidomide (Revlimid) | $2.15B | 130,834 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology